Telemonitoring at scale for hypertension in primary care: An implementation study.


Journal

PLoS medicine
ISSN: 1549-1676
Titre abrégé: PLoS Med
Pays: United States
ID NLM: 101231360

Informations de publication

Date de publication:
06 2020
Historique:
received: 05 09 2019
accepted: 22 05 2020
entrez: 20 6 2020
pubmed: 20 6 2020
medline: 11 8 2020
Statut: epublish

Résumé

While evidence from randomised controlled trials shows that telemonitoring for hypertension is associated with improved blood pressure (BP) control, healthcare systems have been slow to implement it, partly because of inadequate integration with existing clinical practices and electronic records. Neither is it clear if trial findings will be replicated in routine clinical practice at scale. We aimed to explore the feasibility and impact of implementing an integrated telemonitoring system for hypertension into routine primary care. This was a quasi-experimental implementation study with embedded qualitative process evaluation set in primary care in Lothian, Scotland. We described the overall uptake of telemonitoring and uptake in a subgroup of representative practices, used routinely acquired data for a records-based controlled before-and-after study, and collected qualitative data from staff and patient interviews and practice observation. The main outcome measures were intervention uptake, change in BP, change in clinician appointment use, and participants' views on features that facilitated or impeded uptake of the intervention. Seventy-five primary care practices enrolled 3,200 patients with established hypertension. In an evaluation subgroup of 8 practices (905 patients of whom 427 [47%] were female and with median age of 64 years [IQR 56-70, range 22-89] and median Scottish Index of Multiple Deprivation 2012 decile of 8 [IQR 6-10]), mean systolic BP fell by 6.55 mm Hg (SD 15.17), and mean diastolic BP by 4.23 mm Hg (SD 8.68). Compared with the previous year, participating patients made 19% fewer face-to-face appointments, compared with 11% fewer in patients with hypertension who were not telemonitoring. Total consultation time for participants fell by 15.4 minutes (SD 68.4), compared with 5.5 minutes (SD 84.4) in non-telemonitored patients. The convenience of remote collection of BP readings and integration of these readings into routine clinical care was crucial to the success of the implementation. Limitations include the fact that practices and patient participants were self-selected, and younger and more affluent than non-participating patients, and the possibility that regression to the mean may have contributed to the reduction in BP. Routinely acquired data are limited in terms of completeness and accuracy. Telemonitoring for hypertension can be implemented into routine primary care at scale with little impact on clinician workload and results in reductions in BP similar to those in large UK trials. Integrating the telemonitoring readings into routine data handling was crucial to the success of this initiative.

Sections du résumé

BACKGROUND
While evidence from randomised controlled trials shows that telemonitoring for hypertension is associated with improved blood pressure (BP) control, healthcare systems have been slow to implement it, partly because of inadequate integration with existing clinical practices and electronic records. Neither is it clear if trial findings will be replicated in routine clinical practice at scale. We aimed to explore the feasibility and impact of implementing an integrated telemonitoring system for hypertension into routine primary care.
METHODS AND FINDINGS
This was a quasi-experimental implementation study with embedded qualitative process evaluation set in primary care in Lothian, Scotland. We described the overall uptake of telemonitoring and uptake in a subgroup of representative practices, used routinely acquired data for a records-based controlled before-and-after study, and collected qualitative data from staff and patient interviews and practice observation. The main outcome measures were intervention uptake, change in BP, change in clinician appointment use, and participants' views on features that facilitated or impeded uptake of the intervention. Seventy-five primary care practices enrolled 3,200 patients with established hypertension. In an evaluation subgroup of 8 practices (905 patients of whom 427 [47%] were female and with median age of 64 years [IQR 56-70, range 22-89] and median Scottish Index of Multiple Deprivation 2012 decile of 8 [IQR 6-10]), mean systolic BP fell by 6.55 mm Hg (SD 15.17), and mean diastolic BP by 4.23 mm Hg (SD 8.68). Compared with the previous year, participating patients made 19% fewer face-to-face appointments, compared with 11% fewer in patients with hypertension who were not telemonitoring. Total consultation time for participants fell by 15.4 minutes (SD 68.4), compared with 5.5 minutes (SD 84.4) in non-telemonitored patients. The convenience of remote collection of BP readings and integration of these readings into routine clinical care was crucial to the success of the implementation. Limitations include the fact that practices and patient participants were self-selected, and younger and more affluent than non-participating patients, and the possibility that regression to the mean may have contributed to the reduction in BP. Routinely acquired data are limited in terms of completeness and accuracy.
CONCLUSIONS
Telemonitoring for hypertension can be implemented into routine primary care at scale with little impact on clinician workload and results in reductions in BP similar to those in large UK trials. Integrating the telemonitoring readings into routine data handling was crucial to the success of this initiative.

Identifiants

pubmed: 32555625
doi: 10.1371/journal.pmed.1003124
pii: PMEDICINE-D-19-03237
pmc: PMC7299318
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e1003124

Subventions

Organisme : Chief Scientist Office
ID : ARPG/07/03
Pays : United Kingdom
Organisme : Chief Scientist Office
ID : CZH/4/1135
Pays : United Kingdom

Déclaration de conflit d'intérêts

I have read the journal’s policy and the authors of this manuscript have the following competing interests: BM is supported by the Scottish Government in relation to their plans to scale up telemonitoring for hypertension across Scotland. MP is paid by the Scottish Government to give advice on implementing telemonitoring of blood pressure. BM and ASh are in receipt of funding for an unrelated hypertension telemonitoring study of people with stroke. ASh is a member of the Editorial Board of PLOS Medicine. ASt has received research funding for this study and another trial of Telehealth for Blood Pressure. HP has received fundng in the last 3 years from the European EIT Digital fund to develop an app for BP management. All other authors declare no support from any organisation for the submitted work; no financial relationships with any organisations that might have an interest in the submitted work in the previous three years; no other relationships or activities that could appear to have influenced the submitted work.

Références

J Telemed Telecare. 2018 Jan;24(1):4-12
pubmed: 29320966
J Innov Health Inform. 2017 Nov 17;24(4):915
pubmed: 29334351
Lancet. 2012 Dec 15;380(9859):2224-60
pubmed: 23245609
BMJ Open. 2019 Jan 24;9(1):e024970
pubmed: 30679298
Trials. 2015 Mar 25;16:117
pubmed: 25873155
PLoS Med. 2017 Sep 19;14(9):e1002389
pubmed: 28926573
Lancet. 2010 Jul 17;376(9736):163-72
pubmed: 20619448
J Adv Nurs. 2015 Feb;71(2):326-37
pubmed: 25069605
Eur J Prev Cardiol. 2014 Dec;21(12):1517-30
pubmed: 23990660
Interact J Med Res. 2013 Nov 26;2(2):e29
pubmed: 24280631
BMJ. 2009 May 19;338:b1665
pubmed: 19454737
BMJ Open. 2013 May 28;3(5):
pubmed: 23793649
Hypertension. 2011 Jan;57(1):29-38
pubmed: 21115879
SAGE Open Med. 2018 May 17;6:2050312118773261
pubmed: 29796266
BMJ. 2017 Mar 6;356:i6795
pubmed: 28264797
Hypertension. 2019 Jun;73(6):1231-1239
pubmed: 31067190
Hypertension. 2006 Mar;47(3):345-51
pubmed: 16432045
J Hypertens. 2019 Feb;37(2):264-279
pubmed: 30020240
BMJ. 2013 May 24;346:f3030
pubmed: 23709583
Milbank Q. 2004;82(4):581-629
pubmed: 15595944
Implement Sci. 2011 Apr 23;6:42
pubmed: 21513547
BMJ Open. 2018 Jan 31;8(1):e019431
pubmed: 29391369
BMC Fam Pract. 2018 Jul 18;19(1):118
pubmed: 30021535
PLoS Med. 2016 Jul 26;13(7):e1002098
pubmed: 27458809
N Engl J Med. 2005 Aug 4;353(5):487-97
pubmed: 16079372
Hypertension. 2005 Jan;45(1):142-61
pubmed: 15611362
Lancet. 2018 Mar 10;391(10124):949-959
pubmed: 29499873

Auteurs

Vicky Hammersley (V)

Usher Institute, University of Edinburgh, Edinburgh, United Kingdom.

Richard Parker (R)

Usher Institute, University of Edinburgh, Edinburgh, United Kingdom.

Mary Paterson (M)

Usher Institute, University of Edinburgh, Edinburgh, United Kingdom.

Janet Hanley (J)

School of Health and Social Care. Edinburgh Napier University, Edinburgh, United Kingdom.

Hilary Pinnock (H)

Usher Institute, University of Edinburgh, Edinburgh, United Kingdom.

Paul Padfield (P)

Usher Institute, University of Edinburgh, Edinburgh, United Kingdom.

Andrew Stoddart (A)

Usher Institute, University of Edinburgh, Edinburgh, United Kingdom.

Hyeon Gyeong Park (HG)

Usher Institute, University of Edinburgh, Edinburgh, United Kingdom.

Aziz Sheikh (A)

Usher Institute, University of Edinburgh, Edinburgh, United Kingdom.

Brian McKinstry (B)

Usher Institute, University of Edinburgh, Edinburgh, United Kingdom.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH